Clinical Trial Update: A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. [Phase 1]

View source ↗

Summary

This Phase I trial is evaluating the safety and tolerability of LXP1788 Injection in adults with advanced solid tumors and is currently recruiting, including he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Pancreatic Cancer
• Renal Cell Carcinoma
• Solid Tumors

Drugs mentioned

• LXP1788 Injection (LXP1788)

Snippet

Sponsor: LaunXP Biomedical Co., Ltd. | Conditions: Solid Tumor Malignancies, Cancer, Solid Cancers | Phase 1 | Status: RECRUITING